Golden Arrow Merger announced it has cancelled a stockholders meeting scheduled for tomorrow, when investors were expected to vote on a deadline extension from March 19, 2023 to March 19, 2024.
The press release announcing the meeting cancellation provided no other information about the SPAC’s next move. Accordingly, it is unclear if the SPAC will continue to pursue a business combination, run out the clock or take some other action.
Golden Arrow raised $250 million in a March 2021 IPO. At that time the SPAC said it would focus on healthcare or healthcare-related infrastructure industries in the United States and other developed countries. Read more.
